AI Cancer Market to Grow at 23.1% CAGR by 2029

Published Date : 02/01/2025 

Key players in the AI in Cancer market include AZRA AI, CONCERTAI, GE HEALTHCARE, ICAD INC., LUNIT INC., MEDIAN TECHNOLOGIES, NVIDIA CORP., and QUEST DIAGNOSTICS INC. 

AI in Cancer Market Set to Expand at an Impressive 23.1% CAGR by 2029

According to the latest study from BCC Research, the market for Artificial Intelligence (AI) in cancer is projected to grow significantly from $2.2 billion in 2024 to reach $6.3 billion by 2029, with a compound annual growth rate (CAGR) of 23.1% over the forecast period.

This report delves into the current and future potential of AI technology in cancer applications, considering market drivers, restraints, and opportunities.

Market Overview

The report segments the market by application, cancer type, and end user.

It provides in-depth projections for the period 2024-2029 and examines the competitive landscape across North America, Europe, Asia Pacific, and the Rest of the World.

Company profiles offer insights into business segments, financials, and recent developments of key players.

Key Market Drivers

1.

AI in Drug Discovery and Development

- AI significantly accelerates drug discovery by analyzing vast datasets to identify potential drug candidates more quickly and accurately than traditional methods.

This leads to faster development of effective cancer treatments, reducing time and costs.

2.

Increasing Incidence of Cancer

- The rising number of cancer cases globally drives the demand for advanced diagnostic and treatment solutions.

AI offers promising tools to improve early detection, personalized treatment plans, and enhance patient outcomes, making it a critical technology in addressing the growing cancer burden.

Market Segmentation

- Cancer Type

- The breast cancer segment is expected to lead the market, growing at a rate of 21.8% due to improved screening and early diagnosis.

- Application

- Applications include screening, diagnosis, therapy, and drug discovery.

Each segment is crucial in leveraging AI to enhance the overall patient care experience.

- End User

- Hospitals, diagnostic centers, and research institutions are key end users of AI in cancer applications.

These entities are increasingly adopting AI technologies to improve patient outcomes and operational efficiency.

Regional Analysis

- North America

- North America currently has the highest market share, driven by the presence of major players and advanced healthcare infrastructure.

- Europe

- Europe is another significant market, with strong healthcare systems and a high adoption rate of AI technologies.

- Asia Pacific

- The Asia Pacific region is expected to witness substantial growth due to increasing awareness and investment in healthcare technologies.

- Rest of the World

- Emerging markets in the Rest of the World are also contributing to market growth, driven by improving healthcare facilities and increasing government support.

Interesting Facts

- Personalized Cancer Treatments

- AI is increasingly being used to create personalized cancer treatments, tailoring therapies to individual patient needs.

- Advanced AI Models

- AI companies and biotech firms are developing models using machine learning, deep learning, generative AI, and federated learning to help discover new drugs.

- Improved Diagnosis

- In the future, AI could greatly assist doctors, oncologists, and radiologists in diagnosing cancer faster and more accurately, leading to better patient outcomes.

Market Leaders

- AZRA AI

- A leading AI company focused on developing advanced solutions for cancer diagnosis and treatment.

- CONCERTAI

- Known for its innovative AI-driven platforms that enhance cancer care and research.

- GE HEALTHCARE

- A global leader in medical technology and digital solutions, GE Healthcare offers a range of AI-powered diagnostic tools.

- ICAD INC.

- Specializes in advanced imaging solutions that leverage AI to improve cancer detection and management.

- LUNIT INC.

- Develops AI-based medical imaging software for early detection and diagnosis of cancers.

- MEDIAN TECHNOLOGIES

- Provides AI-driven imaging solutions to support cancer research and clinical trials.

- NVIDIA CORP.

- Offers powerful AI computing platforms that accelerate the development of cancer diagnostics and treatments.

- QUEST DIAGNOSTICS INC.

- A leading provider of diagnostic testing and information services, incorporating AI to enhance accuracy and efficiency.

- SIEMENS HEALTHINEERS

- A pioneer in medical imaging and AI, Siemens Healthineers develops innovative solutions for cancer care.

Related Reports

- Global Artificial Intelligence (AI) Market Investments vs Potential

- This report examines the global AI market, breaking it down by solution type and deployment mode.

It covers AI technologies like machine learning, computer vision, NLP, and context-aware computing and explores their applications across various industries.

- Artificial Intelligence (AI) in Life Sciences Market

- This report provides an in-depth analysis of the global AI market in life sciences, estimating current and past revenues by product, application, end user, and region.

For further information or to purchase a copy of the report, please contact BCC Research at [email protected] or visit their website.

About BCC Research

BCC Research is a leading provider of market research reports, offering objective and unbiased measurement and assessment of market opportunities.

Their experienced industry analysts aim to help businesses make informed decisions free of noise and hype.

Contact Information

- Corporate HQ 50 Milk St.

Ste 16, Boston, MA 02109, USA

- Email [email protected]

- Phone +1 781-489-7301

- For media inquiries, email [email protected] or visit their media page. 

Frequently Asked Questions (FAQS):

Q: What is the projected growth rate of the AI in cancer market?

A: The AI in cancer market is projected to grow at a compound annual growth rate (CAGR) of 23.1% from 2024 to 2029.

Q: Which cancer type is expected to lead the market by 2029?

A: The breast cancer segment is expected to lead the market, growing at a rate of 21.8% due to improved screening and early diagnosis.

Q: How does AI help in drug discovery and development?

A: AI accelerates drug discovery by analyzing vast datasets to identify potential drug candidates more quickly and accurately than traditional methods, leading to faster development of effective cancer treatments.

Q: Which region currently has the highest market share in the AI in cancer market?

A: North America currently has the highest market share, driven by the presence of major players and advanced healthcare infrastructure.

Q: What are some key applications of AI in cancer care?

A: Key applications of AI in cancer care include screening, diagnosis, therapy, and drug discovery, all of which aim to improve patient outcomes and enhance the overall patient care experience. 

More Related Topics :